#sarepta — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #sarepta, aggregated by home.social.
-
https://www.europesays.com/africa/125092/ Two dead in suspected gang hits #CrimeStop #DailyVoice #HardLivings #hls #KeeromStreet #KuilsRiver #KuilsRiverSaps #Mitchell'sPlain #mitchells #Police #sarepta #serepta #SouthAfrica #tafelsig #Troubles #WesleyTwigg #ZinniaStreet
-
Back then, one patient death was enough to shut down gene therapy research for years. Now, it took three deaths and firm FDA action to stop a company from continuing unfazed.
-
Back then, one patient death was enough to shut down gene therapy research for years. Now, it took three deaths and firm FDA action to stop a company from continuing unfazed.
-
Back then, one patient death was enough to shut down gene therapy research for years. Now, it took three deaths and firm FDA action to stop a company from continuing unfazed.
-
Back then, one patient death was enough to shut down gene therapy research for years. Now, it took three deaths and firm FDA action to stop a company from continuing unfazed.
-
📉 SRPT Stock in 2025: Where Is Sarepta Headed?
Sarepta Therapeutics faces mixed reviews, regulatory hurdles, and gene therapy hopes. We’ve unpacked it all here:
👉 https://allnewtrending.com/sarepta-stock-2025-analysis/#Sarepta #SRPT #StockNews #Biotech #Investing #MastodonFinance #allnewtrending #usa
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Daiichi invests 1 bln eur near Munich to make precision cancer drugs —FDA to review Sarepta's Duchenne gene therapy for traditional approval —Denali-Sanofi's ALS drug fails to meet mid-stage trial goal--http://bit.ly/w28kSd #daiichisankyo #germany #cancer #dmd #sarepta #als #sanofi #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Daiichi invests 1 bln eur near Munich to make precision cancer drugs —FDA to review Sarepta's Duchenne gene therapy for traditional approval —Denali-Sanofi's ALS drug fails to meet mid-stage trial goal--http://bit.ly/w28kSd #daiichisankyo #germany #cancer #dmd #sarepta #als #sanofi #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Daiichi invests 1 bln eur near Munich to make precision cancer drugs —FDA to review Sarepta's Duchenne gene therapy for traditional approval —Denali-Sanofi's ALS drug fails to meet mid-stage trial goal--http://bit.ly/w28kSd #daiichisankyo #germany #cancer #dmd #sarepta #als #sanofi #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Moderna, Regeneron post solid earnings, eye a strong finish to 2023 -- Sarepta offers early look at closely watched gene therapy launch -- Biogen looks at selling biosims unit to longtime ally Samsung Bioepis -- See more on our front page news http://bit.ly/w28kSd #earnings #moderna #regeneron #sarepta #dmd #genetherapy #biogen #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Moderna, Regeneron post solid earnings, eye a strong finish to 2023 -- Sarepta offers early look at closely watched gene therapy launch -- Biogen looks at selling biosims unit to longtime ally Samsung Bioepis -- See more on our front page news http://bit.ly/w28kSd #earnings #moderna #regeneron #sarepta #dmd #genetherapy #biogen #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board? —FDA advisers narrowly vote in favor of Sarepta's DMD gene therapy —Astellas' menopause drug scores FDA approval, after regulatory setback -- See more on our front page news http://bit.ly/w28kSd #pfizer #seagen #antitrust #mergersandacquisitions #fda #hotflashes #genetherapy #menopause #astellas #dmd #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board? —FDA advisers narrowly vote in favor of Sarepta's DMD gene therapy —Astellas' menopause drug scores FDA approval, after regulatory setback -- See more on our front page news http://bit.ly/w28kSd #pfizer #seagen #antitrust #mergersandacquisitions #fda #hotflashes #genetherapy #menopause #astellas #dmd #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
FDA rejects Teva’s high-potency biosimilar of Humira again — After a record run, fewer biotechs are going public— Sarepta shares drop as report says FDA almost rejected under-review gene therapy -- See more on our front page news http://bit.ly/w28kSd #tevapharma #fda #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Spezial-#Newsletter zum #Frauentag 💪
Wir stellen 7 virtuelle Ausstellungen mit weiblichen Hauptrollen vor...
https://www.deutsche-digitale-bibliothek.de/content/node/6539Themen:
- #Plakatgestaltung, Kunstbibliothek
- #Keramikmalerei von Künstlerinnen, Kunstgewerbemuseum
- #TrudeStolpSeitz & #GabrieleDahms, Künstlernachlässe Mannheim
- #MichaelaMeise, Städtische Galerie Nordhorn
- #Sarepta, Von Bodelschwinghsche Stiftungen
- #Streuselkuchen!, Lette Verein Berlin -
Spezial-#Newsletter zum #Frauentag 💪
Wir stellen 7 virtuelle Ausstellungen mit weiblichen Hauptrollen vor...
https://www.deutsche-digitale-bibliothek.de/content/node/6539Themen:
- #Plakatgestaltung, Kunstbibliothek
- #Keramikmalerei von Künstlerinnen, Kunstgewerbemuseum
- #TrudeStolpSeitz & #GabrieleDahms, Künstlernachlässe Mannheim
- #MichaelaMeise, Städtische Galerie Nordhorn
- #Sarepta, Von Bodelschwinghsche Stiftungen
- #Streuselkuchen!, Lette Verein Berlin -
Spezial-#Newsletter zum #Frauentag 💪
Wir stellen 7 virtuelle Ausstellungen mit weiblichen Hauptrollen vor...
https://www.deutsche-digitale-bibliothek.de/content/node/6539Themen:
- #Plakatgestaltung, Kunstbibliothek
- #Keramikmalerei von Künstlerinnen, Kunstgewerbemuseum
- #TrudeStolpSeitz & #GabrieleDahms, Künstlernachlässe Mannheim
- #MichaelaMeise, Städtische Galerie Nordhorn
- #Sarepta, Von Bodelschwinghsche Stiftungen
- #Streuselkuchen!, Lette Verein Berlin -
Spezial-#Newsletter zum #Frauentag 💪
Wir stellen 7 virtuelle Ausstellungen mit weiblichen Hauptrollen vor...
https://www.deutsche-digitale-bibliothek.de/content/node/6539Themen:
- #Plakatgestaltung, Kunstbibliothek
- #Keramikmalerei von Künstlerinnen, Kunstgewerbemuseum
- #TrudeStolpSeitz & #GabrieleDahms, Künstlernachlässe Mannheim
- #MichaelaMeise, Städtische Galerie Nordhorn
- #Sarepta, Von Bodelschwinghsche Stiftungen
- #Streuselkuchen!, Lette Verein Berlin